The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS?

J Obes Metab Syndr · 2022 · PMC8987449 · PMID 35314521

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

32 The weight-losing effects of semaglutide 2.4 mg and tirzepatide 15 mg are highly significant in light of this.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.